연구동향 분석
박사

Clinical significance of circulating endothelial progenitor cells in the patients with liver cirrhosis and hepatocellular carcinoma

조현진 2015년

논문상세정보
인용/피인용
' Clinical significance of circulating endothelial progenitor cells in the patients with liver cirrhosis and hepatocellular carcinoma' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 간경변증
  • 간세포암
  • 내피모세포
  • 혈관내피성장인자
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
64 0

0.0%

' Clinical significance of circulating endothelial progenitor cells in the patients with liver cirrhosis and hepatocellular carcinoma' 의 참고문헌

  • Zeller M, Korandji C, Guilland JC, Sicard P, Vergely C, Lorgis L, Beer JC, Duvillard L, Lagrost AC, Moreau D. 2008. Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction. Arterioscler Thromb Vasc Biol. 28(5):954?960.
  • Yu DC, Chen J, Sun XT, Zhuang LY, Jiang CP, Ding YT. 2010. Mechanism of endothelial progenitor cell recruitment into neo-vessels in adjacent non-tumor tissues in hepatocellular carcinoma. BMC Cancer. 10:435.
  • Yu D, Sun X, Qiu Y, Zhou J, Wu Y, Zhuang L. 2007. Identification and clinical significance of mobilized endothelial progenitor cells in tumor vasculogenesis of hepatocellular carcinoma. Clin Cancer Res.13(13):3814?3824.
  • Yip HK, Tsai TH, Lin HS, Chen SF, Sun CK, Leu S, Yuen CM, Tan TY, Lan MY, Liou CW. 2011. Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke. Crit Care. 15(1):R40.
  • Yip HK, Chang LT, Sun CK, Sheu JJ, Chiang CH, Youssef AA, Lee FY, Wu CJ, Fu M. 2008. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats. Crit Care Med. 36(3):873?880.
  • Yip HK, Chang LT, Chang WN, Lu CH, Liou CW, Lan MY, Liu JS, Youssef AA, Chang HW. 2008. Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke. 39(1):69?74.
  • Yeh KH, Sheu JJ, Lin YC, Sun CK, Chang LT, Kao YH, Yen CH, Shao PL, Tsai TH, Chen YL. 2012. Benefit of combined extracorporeal shock wave and bone marrow-derived endothelial progenitor cells in protection against critical limb ischemia in rats. Crit Care Med. 40(1):169?177.
  • Wang S, Cui J, Peng W, Lu M. 2010. Intracoronary autologous CD34+ stem cell therapy for intractable angina. Cardiology. 117(2):140?147.
  • Wang CH, Verma S, Hsieh IC, Chen YJ, Kuo LT, Yang NI, Wang SY, Wu MY, Hsu CM, Cheng CW, Cherng WJ. 2006. Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system. J Mol Cell Cardiol. 41(1):34?43.
  • Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, Dimmeler S. 2001. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation. 103(24):2885?2890.
  • Valgimigli M, Rigolin GM, Fucili A, Porta MD, Soukhomovskaia O, Malagutti P, Bugli AM, Bragotti LZ, Francolini G, Mauro E. 2004. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation. 110(10):1209?1212.
  • Ueno S, Tanabe G, Nuruki K, Hamanoue M, Komorizono Y, Oketani M, Hokotate H, Inoue H, Baba Y, Imamura Y, Aikou T. 2002. Prognostic performance of the new classification of primary liver cancer of Japan (4th edition) for patients with hepatocellular carcinoma: a validation analysis. Hepatol Res. 24(4):395-403.
  • Thabut D, Shah V. 2010. Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension? J Hepatol. 53(5):976-980.
  • Tendera M, Wojakowski W, Ruzyllo W, Chojnowska L, Kepka C, Tracz W, Musialek P, Piwowarska W, Nessler J, Buszman P. 2009. Intracoronary infusion of bone marrow-derived selected CD34 + CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J. 30(11):1313?1321.
  • Sieghart W, Fellner S, Reiberger T, Ulbrich G, Ferlitsch A, Wacheck V, Peck- Radosavljevic M. 2009. Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma. Dig Liver Dis. 41(12):902?906.
  • Shantsila E, Watson T, Lip GY. 2007. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol. 49(7):741?752.
  • Sabatier F, Camoin-Jau L, Anfosso F, Sampol J, Dignat-George F. 2009. Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence. J Cell Mol Med. 13(3):454?471.
  • Risau W, Flamme I. 1995. Vasculogenesis. Annu Rev Cell Dev Biol.11:73-91.
  • Prior,B.M.,Yang,H.T.,& Terjung,R.L.(2004).Whatmakes vessels grow withexercisetraining?.J,Appl.Physiol,97(3),1119-1128.
  • Miller-Kasprzak E, Jagodzinski PP. 2007. Endothelial progenitor cells as a new agent contributing to vascular repair. Arch Immunol Ther Exp. 55(4):247?259.
  • McDougall SR, Anderson AR, Chaplain MA. 2006. Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies. J Theor Biol. 241(3):564-589.
  • Mas VR, Maluf DG, Archer KJ, Yanek KC, Fisher RA. 2007. Angiogenesis soluble factors as hepatocellular carcinoma noninvasive markers for monitoring hepatitis C virus cirrhotic patients awaiting liver transplantation. Transplantation. 84(10):1262?1271.
  • Makris M, Garson JA, Ring CJ, Tuke PW, Tedder RS, Preston FE. 1993. Hepatitis C viral RNA in clotting factor concentrates and the development of hepatitis in recipients. Blood. 81(7):1898?1902.
  • Lemoli RM, Catani L, Talarico S, Loggi E, Gramenzi A, Baccarani U. 2006. Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection. Stem Cells.24(12):2817?2825.
  • Lee, S., Chen, T.T., Barber, C.L., Jordan, M.C., Murdock, J., Desai, S. 2007. Autocrine VEGF signaling is required for vascular homeostasis. Cell. 130(4):691- 703.
  • Kocher AA, Schuster MD, Bonaros N, Lietz K, Xiang G, Martens TP, Kurlansky PA, Sondermeijer H, Witkowski P, Boyle A. 2006. Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines. J Mol Cell Cardiol. 40(4):455?464.
  • Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T. 2000. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA.97(7):3422?3427.
  • Imanishi T, Tsujioka H, Akasaka T. 2008. Endothelial progenitor cells dysfunction and senescence: contribution to oxidative stress. Curr Cardiol Rev. 4(4):275?286.
  • Huang PH, Chen YH, Wang CH, Chen JS, Tsai HY, Lin FY, Lo WY, Wu TC, Sata M, Chen JW, Lin SJ. 2009. Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 29(8):1179?1184.
  • Hong F, Tuyama A, Lee TF, Loke J, Agarwal R, Cheng X, Garg A, Fiel MI, Schwartz M, Walewski J. 2009. Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha- mediated stellate cell activation. Hepatology. 49(6):2055?2067.
  • Ho JW, Pang RW, Lau C, Sun CK, Yu WC, Fan ST. 2006. Significance of circulating endothelial progenitor cells in hepatocellular carcinoma. Hepatology.44(4):836?843.
  • Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. 2003. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 348(7):593?600.
  • Gustafsson T, Bodin K, Sylven C, Gordon A, Tyni-Lenne R, and Jansson E. 2001. Increased expression of VEGF following exercise training in patients with heart failure. Eur J Clin Invest. 31(4): 362?366.
  • Goto F, Goto K, Weindel K, and Folkman J. 1993. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest. 69(5): 508?517.
  • Garcia-Pagan JC, Gracia-Sancho J, Bosch J. 2012. Functional aspects on the pathophysiology of portal hypertension in cirrhosis. J Hepatol. 57(2):458-461.
  • Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V. 2008. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science. 319(5860):195?198.
  • Gadelhak NA, Gadelhak SA, El-Morsi DA, Abdelaziz MM, Abbas AT, El- Emshaty HM. 2009. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma. Hepatogastroenterology.56(94-95):1417?1424.
  • Fadini GP, Losordo D, Dimmeler S. 2012. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res. 110(4):624? 637.
  • Erg n S, Hohn HP, Kilic N, Singer BB, Tilki D. 2008. Endothelial and hematopoietic progenitor cells (EPCs and HPCs): hand in hand fate determining partners for cancer cells. Stem Cell Rev. 4(3):169?177.
  • Egginton S, Zhou AL, Brown MD, Hudlick O. 2001. Unorthodox angiogenesis in skeletal muscle. Cardiovasc Res. 49(3):634-646.
  • Djonov V, Baum O, Burri PH. 2003. Vascular remodeling by intussusceptive angiogenesis.Cell Tissue Res. 314(1):107-117.
  • Dawson JM and Hudlicka O. 1989. The effects of long term administration of prazosin on the microcirculation in skeletal muscles. Cardiovasc Res. 23(11):913? 920.
  • Cunningham SA, Tran TM, Arrate MP, Bjercke R, and Brock TA. 1999. KDR activation is crucial for VEGF165-mediated Ca2 mobilization in human umbilical vein endothelial cells. Am J Physiol Cell Physiol. 276(1):C176?C181.
  • Corpechot, C., Barbu, V., Wendum, D., Kinnman, N., Rey, C., Poupon, R. 2002. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology. 35(5):1010- 1021.
  • Chen CH, Chang LT, Tung WC, Chen YL, Chang CL, Leu S, Sun CK, Tsai TH, Tsai IT, Chang HW, Yip HK. 2012. Levels and values of circulating endothelial progenitor cells, soluble angiogenic factors, and mononuclear cell apoptosis in liver cirrhosis patients. J Biomed Sci. 19:66.
  • Carmeliet, P. 2005. Angiogenesis in life, disease and medicine. Nature. 438(7070):932?936
  • But DY, Lai CL, Yuen MF. 2008. Natural history of hepatitis-related hepatocellular carcinoma. World J Gastroenterol. 14(11):1652?1656.
  • Bruix J, Sherman M. American Association for the Study of Liver Diseases. 2011. Management of hepatocellular carcinoma: an update. Hepatology. 53(3):1020-1022.
  • Bowles DK, Woodman CR, and Laughlin MH. 2000. Coronary smooth muscle and endothelial adaptations to exercise training. Exerc Sport Sci Rev. 28(2): 57?62.
  • Bosch J, Abraldes JG, Fernandez M, Garcia-Pagan JC. 2010. Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension. J Hepatol. 53(3):558-567.
  • Birbrair A, Zhang T, Wang ZM, Messi ML, Olson JD, Mintz A, Delbono O. 2014. Type-2 pericytes participate in normal and tumoral angiogenesis. Am J Physiol Cell Physiol. 307(1):C25-C38.
  • Aucejo F, Kim R, Zein N, Quintini C, Uso TD, Lopez R, Eghtesad B, Fung J, Miller C, Yerian L. 2009. Vascular endothelial growth factor receptor 2 expression in non-tumorous cirrhotic liver is higher when hepatoma is beyond Milan criteria. Liver Transpl. 15(2):169?176.
  • Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 275(5302):964?967.
  • Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW. 2004. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res.10(20):6897-6904.
  • ?Lee, J.S., Semela, D., Iredale, J., and Shah, V.H. 2007. Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte? Hepatology. 45(3):817-825